Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 3136 for “"immunotherapy"”.
-
Immunotherapy hyperprogression
Καθώς διευρύνονται οι γνώσεις στους τομείς της Μοριακής Βιολογίας και της Γενετικής σχετικά με το ανθρώπινο ανοσοποιητικό σύστημα, η έρευνα για τον καρκίνο αυξάνεται ακολούθως ραγδαία. Είναι γεγονός ότι μόλις τα φυσιολογικά κύτταρα μετατραπούν σε καρκινικά, προσπαθούν να αποφύγουν το ανοσοποιητικό …
-
Sublingual Immunotherapy
… have been developed, including sublingual immunotherapy tablets. Furthermore, no longer must a patient endure allergy shots; this can now be delivered sublingually. Although this method has been shown to have high safety and efficacy, very few clinicians actually utilize this form of …
-
Immunotherapy of bladder cancer
In this study, we evaluated the feasibility and efficacy of cytokine gene therapy in a murine orthotopic model of TCC. Orthotopic tumor was established with 1 x 105 MB49 cells in C57BL/6 mice using a modified electro-cautery technique. In situ gene transfer to bladder tumors was accomplished via …
-
Immunotherapy for autoimmune diabetes
[ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI-COLUMBIA AT AUTHOR'S REQUEST.] Type I diabetes (TID) or insulin-dependent diabetes mellitus (IDDM) is an immunemediated disease in which the beta ([beta]) cells of the pancreatic islets of Langerhans are destroyed as a consequence of inflammatory …
-
Immunotherapy in multiple myeloma
… therapies for MM, and suggest that a combined immunotherapy approach using pre-stimulated T cells, MM Ag primed DC and IL-2 may produce better clinical responses in MM patients.
-
Immunotherapy for murine glioma
Oncolytic viral immunotherapy is a novel approach to cancer treatment. Viruses can directly kill cancer cells, provide antigens to dendritic cells to stimulate a T cell response, and make cancer cells express genes of immune-enhancing cytokines locally within the tumor microenvironment. We …
-
Microbubble-Assisted Ultrasound Guided Immunotherapy of Cancer: A Novel Microbubble Platform for Cancer Immunotherapy
The recent success of immunotherapy for treatment-refractory metastatic melanoma, lung cancer, and renal cell carcinoma has provided a new hope that immunotherapy can be generalized to a broader range of cancers. However, many cancers do not respond to immunotherapy, which has limited its use to a …
-
Chemistry meets Cancer Immunotherapy: Synthesis and Characterization of Hapten-like Compounds for Selective Immunotherapy
Chimeric antigen receptors (CARs) are able to specifically direct T cells to tumor antigens and therapy with anti-CD19 CARs has already cured cancer patients with B-cell lymphomas who have undergone long-term therapy non-successful. Despite this impressive result, the therapy is currently only …
-
TARGETING PTPN22 FOR CANCER IMMUNOTHERAPY
Immunotherapies have shown remarkable success in cancer treatment. However, diverse tumor-specific immunosuppressive mechanisms dampen response rates highlighting the need for novel immunotherapeutic targets. Protein Tyrosine Phosphatase Non-Receptor Type 22 (PTPN22) is a phosphatase specific to …
-
IMMUNOTHERAPY FOR T CELL MALIGNANCIES
Antibody and chimeric antigen receptor (CAR) T cell-mediated targeted therapies have improved survival in patients with solid and hematologic malignancies. However, adults with T cell leukemias and lymphomas, collectively called T cell cancers, still face short survival and lack effective targeted …
-
NANOPARTICLE APPROACH TO CANCER IMMUNOTHERAPY
… corona with the use of tumor lysate as a form of immunotherapy in combination with PDT and PTT to demonstrate tri-modal photoimmunotherapy, where both complete cancer cell kill through PDT and PTT and immune activation with the tumor lysate can be achieved in vitro. The findings from this thesis …
-
IMMUNOTHERAPY TARGETING RON IN CANCER
Recepteur d'origine nantais (RON) receptor tyrosine kinase (RTK) and its ligand, macrophage-stimulating protein (MSP), are vital players in cell proliferation, inflammation, epithelial to mesenchymal transition during carcinogenesis, as well as migration and invasion, angiogenesis and …
-
Overcoming Obstacles to Glioma Immunotherapy
… of ex vivo expanded T cells for adoptive immunotherapy that is associated with diminished proliferative potential in vivo. A focus in these experiments is the targeting of tumors with T cells that are specific for antigenic determinants derived from tumor-specific mutations. Engineered T …
-
Novel immunotherapy for paediatric cancers
Chimeric antigen receptors (CAR) are synthetic receptors that redirect T lymphocytes to specific tumour antigens. CART cells targeting CD19 (CAR19) have demonstrated remarkable efficacy against B cell malignancies in clinic. Currently used methods of CAR gene transfer to T cells based on viral …
-
Dendritic cells in cancer immunotherapy.
Radboud Universiteit Nijmegen, 06 december 2010
-
Precision immunotherapy in gynecological cancer
Radboud University, 07 oktober 2026
-
Regulatory T-cells for immunotherapy
Contains fulltext : 106931.pdf (Publisher’s version ) (Open Access)
Page 1 of 157